BioLife Solutions
Supplies preservation media and cell-processing tools for cell and gene therapy workflows.
$36.38
After-hours close−0.01 (−0.03%)
At close$36.39(−2.18%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 104.47%Insiders 4.00%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 48.86M · Float 42.68M · 87.4% free float
Institutions13F, as of Jun 30, 2026
220 holders · 51.04M shares · 58 new positions · 140 increased · 54 reduced · 29 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.75M | 13.82% | +244.8K | Aug 14, 2026 |
| BlackRock, Inc. | 6.38M | 13.05% | +273.8K | Aug 7, 2026 |
| Casdin Capital, LLC | 4.66M | 9.53% | −1.30M | Aug 14, 2026 |
| Invesco Ltd. | 2.24M | 4.59% | −108.1K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.96M | 4.02% | +46.4K | Aug 13, 2026 |
| State Street Corp | 1.66M | 3.39% | +78.9K | Aug 7, 2026 |
| Geode Capital Management, LLC | 1.09M | 2.22% | +114.9K | Aug 12, 2026 |
| Massachusetts Financial Services Co /MA/ | 1.08M | 2.21% | −118.0K | Aug 3, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13.50% | 6.51M | 13G | May 15, 2026 ↗ |
| Casdin Capital, LLC | 9.70% | 4.76M | 13G | Jun 4, 2026 ↗ |
| Casdin Partners Master Fund, L.P.incl. Casdin Capital, LLC, Eli Casdin +1 more | 9.70% | 4.76M | 13D | May 22, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Casdin Partners Master Fund, L.P. | 10 percent owner | 4.76M | 9.74% | May 21, 2026 |
| Roderick de Greef | director, officer: President and CEO | 731.0K | 1.50% | Jun 22, 2026 |
| Aby J. Mathew | officer: EVP & Chief Scientific Officer | 388.5K | 0.80% | Jul 13, 2026 |
| Troy Wichterman | officer: Chief Financial Officer | 213.2K | 0.44% | Jul 13, 2026 |
| Todd Berard | officer: Chief Marketing Officer | 162.6K | 0.33% | Jul 13, 2026 |
| Karen A. Foster | officer: Chief Quality and Operations | 108.8K | 0.22% | Mar 31, 2026 |
| Sarah Aebersold | officer: Chief Human Resources Officer | 92.4K | 0.19% | Mar 23, 2026 |
| Rachel Ellingson | director | 58.0K | 0.12% | Feb 26, 2026 |
| Joydeep Goswami | director | 53.2K | 0.11% | Feb 26, 2026 |
| Sean Werner | officer: Chief Technology Officer | 47.6K | 0.10% | Jul 21, 2026 |
5 ten-percent owners hold 11.71M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 13 people have not refiled in the last 18 months (699.5K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 21, 2026 | Casdin Partners Master Fund, L.P.10 percent owner | Sale | 650,000 | $23.70 | 4,757,165 |
| May 20, 2026 | Casdin Partners Master Fund, L.P.10 percent owner | Sale | 250,000 | $23.70 | 5,407,165 |
| May 19, 2026 | Casdin Partners Master Fund, L.P.10 percent owner | Sale | 300,000 | $22.65 | 5,657,165 |
| Mar 23, 2026 | Karen A. Fosterofficer: Chief Quality and Operations | Sale | 2,577 | $19.17 | 108,758 |
| Mar 9, 2026 | Karen A. Fosterofficer: Chief Quality and Operations | Sale | 500 | $20.00 | 113,242 |
| Mar 5, 2026 | Karen A. Fosterofficer: Chief Quality and Operations | Sale | 96,923 | $20.15 | 113,742 |
| Mar 3, 2026 | Todd Berardofficer: Chief Marketing Officer | Sale | 353 | $20.74 | 165,940 |
| Mar 3, 2026 | Sarah Aebersoldofficer: Chief Human Resources Officer | Sale | 219 | $20.74 | 93,360 |
| Mar 3, 2026 | Troy Wichtermanofficer: Chief Financial Officer | Sale | 588 | $20.74 | 220,649 |
| Mar 3, 2026 | Aby J. Mathewofficer: EVP & Chief Scientific Officer | Sale | 529 | $20.74 | 392,937 |
CongressHouse and Senate disclosures
Not reported.